Literature DB >> 17658120

Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract.

Jay Udani1, Betsy B Singh.   

Abstract

BACKGROUND: A proprietary fractionated white bean extract of Phaseolus vulgaris has been shown in vitro to inhibit the digestive enzyme alpha-amylase. This may prevent or delay the digestion of complex carbohydrates, potentially resulting in weight loss.
METHODS: A 4-week randomized, double-blind, placebo-controlled study of 25 healthy subjects consuming 1000 mg of a proprietary fractioned white bean extract or an identical placebo twice a day before meals in conjunction with a multi-component weight-loss program, including diet, exercise, and behavioral intervention, was conducted.
RESULTS: Both groups reduced their weight and waist size significantly from baseline. The active group lost 6.0 lbs (P=.0002) and 2.2 in (P=.0050), and the placebo group lost 4.7 lbs (P=.0016) and 2.1 in (P=.0001). The differences between groups were not significant (weight P=.4235, waist size P=.8654). Through subsequent exploratory analysis to investigate group findings further, subjects were stratified by total dietary carbohydrate intake. This probative analysis revealed that the tertile of subjects who had consumed the most carbohydrates demonstrated significant reductions in both weight (8.7 lbs vs 1.7 lbs, P=.0412) and waist size (3.3 in vs 1.3 in P=.0100) compared with placebo subjects in the same tertile of carbohydrate intake.
CONCLUSION: Subjects who adhere to a program including dietary modification, exercise, and behavioral intervention can significantly reduce their weight and waist size in a short period of time. In an exploratory analysis of data, the tertile of subjects who ate the most carbohydrates experienced a significant reduction in both weight and waist size with the addition of the white bean extract compared to the placebo group of the same tertile of carbohydrate consumption. Longer studies with a larger pool of subjects are required to validate these findings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658120

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  14 in total

1.  Pulse consumption, satiety, and weight management.

Authors:  Megan A McCrory; Bruce R Hamaker; Jennifer C Lovejoy; Petra E Eichelsdoerfer
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

Review 2.  A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control.

Authors:  Marilyn L Barrett; Jay K Udani
Journal:  Nutr J       Date:  2011-03-17       Impact factor: 3.271

Review 3.  A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity.

Authors:  Shirin Hasani-Ranjbar; Neda Nayebi; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

4.  The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.

Authors:  Sonia A Tucci; Emma J Boyland; Jason Cg Halford
Journal:  Diabetes Metab Syndr Obes       Date:  2010-05-10       Impact factor: 3.168

5.  Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism.

Authors:  Mauro Am Carai; Noemi Fantini; Barbara Loi; Giancarlo Colombo; Antonella Riva; Paolo Morazzoni
Journal:  Diabetes Metab Syndr Obes       Date:  2009-09-07       Impact factor: 3.168

Review 6.  The active role of leguminous plant components in type 2 diabetes.

Authors:  Monika Gętek; Natalia Czech; Małgorzata Muc-Wierzgoń; Elżbieta Grochowska-Niedworok; Teresa Kokot; Ewa Nowakowska-Zajdel
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-11       Impact factor: 2.629

7.  Systematic Review and Meta-Analysis of a Proprietary Alpha-Amylase Inhibitor from White Bean (Phaseolus vulgaris L.) on Weight and Fat Loss in Humans.

Authors:  Jay Udani; Ollie Tan; Jhanna Molina
Journal:  Foods       Date:  2018-04-20

8.  Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches.

Authors:  Shiqi Luo; George Binh Lenon; Harsharn Gill; Andrew Hung; Daniel A Dias; Mingdi Li; Linh Toan Nguyen
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

9.  A Phaseolus vulgaris Extract Reduces Cue-Induced Reinstatement of Chocolate Seeking in Rats.

Authors:  Irene Lorrai; Valentina Piga; Mauro A M Carai; Antonella Riva; Paolo Morazzoni; Gian Luigi Gessa; Giancarlo Colombo; Paola Maccioni
Journal:  Front Pharmacol       Date:  2016-04-26       Impact factor: 5.810

Review 10.  It's No Has Bean: A Review of the Effects of White Kidney Bean Extract on Body Composition and Metabolic Health.

Authors:  Ruth Nolan; Oliver M Shannon; Natassia Robinson; Abraham Joel; David Houghton; Fiona C Malcomson
Journal:  Nutrients       Date:  2020-05-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.